Literature DB >> 32352877

Analysis of pain symptoms, flexibility and hydroxyproline concentration in individuals with low back pain submitted to Global Postural Re-education and stretching.

Frederico Pecorone Matos1, Estélio Henrique Martin Dantas2,3, Flávio Boechat de Oliveira1,4,5, Juliana Brandão Pinto de Castro4,5, Mario Cezar de S Costa Conceição4,5, Rodolfo de Alkmim Moreira Nunes4,5, Rodrigo Gomes de Souza Vale1,4,5,6.   

Abstract

Aim: To evaluate pain, flexibility and hydroxyproline (HP) urinary levels in patients with nonspecific low back pain submitted to Global Postural Re-education (GPR) and stretching. Materials & methods: 39 individuals who reported low back pain were randomly assigned to a group submitted to GPR (GPRG) or stretching exercises (SG) for 8 weeks. Pain and flexibility were assessed using the Borg CR10 scale and goniometry, respectively.
Results: The GPR group showed a significant reduction in the HP levels and significant improvements in flexibility after the intervention when compared with SG. Both groups presented a significant reduction in HP and pain after the intervention.
Conclusion: Both interventions were effective in the treatment of low back pain. However, the GPR method presented better responses than stretching.

Entities:  

Keywords:  exercise; flexibility; hydroxyproline; low back pain; rehabilitation; spine

Mesh：

Substances：

Year:  2020        PMID： 32352877     DOI： 10.2217/pmt-2019-0053

Source DB:  PubMed          Journal:  Pain Manag        ISSN： 1758-1869


  2 in total

Review 1.  Exercise therapy for chronic low back pain.

Authors:  Jill A Hayden; Jenna Ellis; Rachel Ogilvie; Antti Malmivaara; Maurits W van Tulder
Journal:  Cochrane Database Syst Rev       Date:  2021-09-28

2.  Acute Effects of Global Postural Re-Education on Non-Specific Low Back Pain. Does Time-of-Day Play a Role?

Authors:  David Merinero; Manuel Rodríguez-Aragón; Javier Álvarez-González; Álvaro López-Samanes; Joaquín López-Pascual
Journal:  Int J Environ Res Public Health       Date:  2021-01-15       Impact factor: 3.390
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.